Home/Filings/4/0001437749-26-001016
4//SEC Filing

WEISS MICHAEL S 4

Accession 0001437749-26-001016

CIK 0001001316other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 5:16 PM ET

Size

5.3 KB

Accession

0001437749-26-001016

Insider Transaction Report

Form 4
Period: 2026-01-08
WEISS MICHAEL S
DirectorCEO
Transactions
  • Award

    Common Stock

    2026-01-08+622,0009,778,086 total
Footnotes (2)
  • [F1]Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period.
  • [F2]Includes shares of restricted Common Stock, which vest over various time periods.

Issuer

TG THERAPEUTICS, INC.

CIK 0001001316

Entity typeother

Related Parties

1
  • filerCIK 0001038977

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:16 PM ET
Size
5.3 KB